fig2
![HDL subfraction distribution and HDL function in untreated dyslipidemic patients](https://image.oaes.cc/cac32c4d-a4b7-49d1-bf6a-18837a9c6a3c/2194.fig.2.png)
Figure 2. Levels of serum MPO (A), MPO/PON1 ratio (B), activities of serum paraoxonase (C), and arylesterase (D) in dyslipidemic patients and controls. MPO: myeloperoxidase; PON1: paraoxonase-1
Figure 2. Levels of serum MPO (A), MPO/PON1 ratio (B), activities of serum paraoxonase (C), and arylesterase (D) in dyslipidemic patients and controls. MPO: myeloperoxidase; PON1: paraoxonase-1
All published articles are preserved here permanently:
https://www.portico.org/publishers/oae/